Nominations for New Community Members of the DHHS Panel on Pediatric Antiretroviral Therapy and Management Guidelines

December 5, 2011

The Department of Health and Human Services (HHS) Panel on Pediatric Antiretroviral Therapy and Management Guidelines (the Pediatric Guidelines Panel) is accepting nominations for new community members with experience related to pediatric HIV infection. The Panel anticipates one vacancy for a 3-year term beginning January 2012, with potential for reappointment for a second term.

The Pediatric Guidelines Panel is a working group of the Office of AIDS Research Advisory Council (OARAC) of the National Institutes of Health (NIH). The Panel is composed of approximately 25 members who are clinicians, researchers, academicians, HHS representatives with expertise in pediatric HIV management, and community representatives with knowledge of HIV infection in children. The Panel meets monthly via teleconferencing and on occasion in person to review and critically evaluate emerging scientific data relating to antiretroviral therapy in infants and children. Panel members actively engage in the preparation and update of the "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection." The document is widely used by HIV practitioners and researchers in the United States. (To view the latest version of the guidelines visit the AIDSinfo clinical guidelines portal.)

Community members serve two important roles on guidelines panel committees:

  1. To help the groups maintain their focus on patient care;
  2. To ensure that the guidelines are realistic in terms of the lives of persons with HIV/AIDS in the United States.

Community members are full, voting members of the Panel and participate in monthly conference calls and any other meetings of the Panel; actively participate in discussions of revisions to the guidelines; serve on revision working subgroups when relevant; and vote on revisions to the guidelines.


Requirements for community members include knowledge and involvement in issues related to HIV infection in women and/or children as evidenced by participation in community advisory boards or liaisons to clinical centers or trials networks that include a focus on women and/or children, membership in relevant non-governmental community organizations that have a focus on HIV in women and/or children, or experience in providing consultation on issues related to HIV in women and/or children to professional organizations or governmental agencies.

Panel members are not compensated for their time commitment and travel support is not provided for participation. Because these guidelines focus on pediatric antiretroviral management in the United States, candidates must be from the United States. Candidates should be willing to dedicate the necessary time to participate on the Working Group—a minimum of monthly conference calls and willingness to actively write revisions. The successful candidate shall serve a 3-year term starting in January 2012.

Please include with nominations a resume describing the candidate's involvement in pediatric HIV care and/or community advisory boards and a letter of nomination or letter of interest outlining what qualities and contributions the candidate may bring to the Panel. The deadline for nominations is December 30, 2011. Please e-mail nominations to Lynne M. Mofenson, M.D., Panel Executive Secretary, at or or send to the following address: Lynne M. Mofenson, M.D., National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Boulevard, Room 4B11, Rockville, MD 20852 (Fax: 301-496-8678).

This article was provided by AIDSinfo. Visit the AIDSinfo website to find out more about their activities and publications.
See Also
Read the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (PDF)

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.